Work

Phase I study of MK-3475 (anti-PD-1 monoclonal antibody) in patients with advanced solid tumors.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.2512

Authors: Amita Patnaik, Soonmo Peter Kang, Anthony W. Tolcher, Drew Warren Rasco, Kyriakos P. Papadopoulos, Muralidhar Beeram, Ronald Drengler, Cong Chen, Lon Smith, Crystal Perez, Kevin Gergich, Manfred Lehnert

Institutions: South Texas Accelerated Research Therapeutics, Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2249078564

Cites:

Cited by: 82

Related to: 10